Literature DB >> 15811620

Does the vagus nerve inform the brain about preclinical tumours and modulate them?

Yori Gidron1, Hugh Perry, Martin Glennie.   

Abstract

The inflammatory microenvironment is thought to play a pivotal part in tumorigenesis. But, can the brain be informed about peripheral preclinical cancer cells? Can it modulate tumour development? One of the key routes for information to reach the brain from visceral regions is through the vagus nerve. Yet, patients with ulcers who have had a vagotomy have been shown to die from cancer more frequently than do those who have not had this procedure, and surgical and chemical vagotomy attenuates tumour-induced anorexia and leads to enhanced tumour progression. We therefore postulate that the vagus nerve participates in informing the brain about tumorigenesis by transmiting information to the brain about tumour-associated proinflammatory cytokines. Furthermore, activation of the vagus could slow tumorigenesis by suppression of peripheral proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15811620     DOI: 10.1016/S1470-2045(05)70096-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  31 in total

Review 1.  Mechanisms and Therapeutic Relevance of Neuro-immune Communication.

Authors:  Sangeeta S Chavan; Valentin A Pavlov; Kevin J Tracey
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

2.  Cholinergic modulation of inflammation.

Authors:  Valentin A Pavlov
Journal:  Int J Clin Exp Med       Date:  2008-06-05

3.  Reply to the letter "Cardiac autonomic evaluation in breast cancer patients: role of cytokines and heart rate recovery".

Authors:  Claudia Arab; Luiz Carlos Marques Vanderlei; Yori Gidron; Celso Ferreira
Journal:  Clin Res Cardiol       Date:  2018-06-14       Impact factor: 5.460

Review 4.  Neural circuitry and immunity.

Authors:  Valentin A Pavlov; Kevin J Tracey
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 5.  Autonomic nervous system and cancer.

Authors:  Marta Simó; Xavier Navarro; Victor J Yuste; Jordi Bruna
Journal:  Clin Auton Res       Date:  2018-03-28       Impact factor: 4.435

6.  Evidence of altered autonomic cardiac regulation in breast cancer survivors.

Authors:  Chiara Vigo; Wolfgang Gatzemeier; Roberto Sala; Mara Malacarne; Armando Santoro; Massimo Pagani; Daniela Lucini
Journal:  J Cancer Surviv       Date:  2015-04-22       Impact factor: 4.442

Review 7.  Schwann cells: a new player in the tumor microenvironment.

Authors:  Yuri L Bunimovich; Anton A Keskinov; Galina V Shurin; Michael R Shurin
Journal:  Cancer Immunol Immunother       Date:  2016-11-24       Impact factor: 6.968

8.  Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis.

Authors:  Janine Giese-Davis; Kate Collie; Kate M S Rancourt; Eric Neri; Helena C Kraemer; David Spiegel
Journal:  J Clin Oncol       Date:  2010-12-13       Impact factor: 44.544

9.  Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists.

Authors:  A Molinos-Quintana; P Trujillo-Hacha; J I Piruat; J A Bejarano-García; E García-Guerrero; J A Pérez-Simón; Miguel Muñoz
Journal:  Invest New Drugs       Date:  2018-05-02       Impact factor: 3.850

10.  Cardiac autonomic modulation impairments in advanced breast cancer patients.

Authors:  Claudia Arab; Luiz Carlos Marques Vanderlei; Laércio da Silva Paiva; Kyle Levi Fulghum; Carlos Elias Fristachi; Afonso Celso Pinto Nazario; Simone Elias; Luiz Henrique Gebrim; Celso Ferreira Filho; Yori Gidron; Celso Ferreira
Journal:  Clin Res Cardiol       Date:  2018-05-02       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.